Stay updated on STK-012 in Solid Tumors with Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.

Latest updates to the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA new record-history version dated October 29, 2026, was added, documenting changes to the study status and contacts/locations. The page’s displayed site revision was also updated.SummaryDifference0.5%

- Check25 days agoChange DetectedA banner announces an NIH website transition and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference0.6%

- Check32 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check39 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site as revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check59 days agoChange DetectedThe history section now surfaces a 'Find contact information' item and shows the latest revision tag 'Revision: v3.7.0'. This replaces the prior 'Find Contact Information' label and the older 'Revision: v3.6.6'.SummaryDifference0.2%

- Check80 days agoChange DetectedThe record history shows Revision: v3.6.6, indicating a new revision of the study record was posted, replacing the previous v3.6.5.SummaryDifference0.1%

Stay in the know with updates to STK-012 in Solid Tumors with Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.